Jefferies Starts Liquidia Technologies (LQDA) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Needham & Company Starts Liquidia Technologies (LQDA) at Buy
August 20, 2018 6:57 AM EDTNeedham & Company analyst Serge Belanger initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Buy rating and a price target of $30.00.
Belanger commented, "We initiate coverage of Liquidia Technologies (LQDA), a late-stage biopharma developing LIQ861, a differentiated inhaled PAH treatment based on its... More
Cowen Starts Liquidia Technologies (LQDA) at Outperform
August 20, 2018 5:40 AM EDTCowen analyst Ken Cacciatore initiates coverage on Liquidia Technologies (NASDAQ: LQDA) with a Outperform rating and a price target of $40.00.
The analyst comments "The lead asset is LIQ861 for PAH, an inhaled reformulation of a known active molecule, treprostinil, that is more optimally... More
